The strategy of performing perfusion/metabolic imaging before amyloid or tau PET can save costs providing a wider spectrum of differential diagnosis of dementia based on the recognition of specific disease patterns and reserving the more complex molecular imaging tools for undetermined cases (Figures 1, 2 show examples of this approach). Here, MAPT is linked to dementia.